Skip to main navigation
Harvard Bioscience Logo
  • About Us
    • Overview
    • History
    • Global Sites
    • Leadership Team
    • Our Vision
    • Careers
    • Contact Us
    • Code of Conduct
    • Privacy Policy
  • Our Global Brands
  • Investor Relations
    • Investor Overview
    • Corporate Governance
      • Leadership Team
      • Board of Directors
      • Committee Composition
      • Contact the Board
    • Financials & Filings
      • SEC Filings
      • Annual Reports
      • Quarterly Results
      • Key Ratios
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
    • Analyst Coverage
    • Investor FAQs
    • Contact Us
  • News + Events
    • Press Releases
    • Events & Presentations
    • Email Alerts
  • Contact Us
  • Careers
Investor Relations
harvardbio-IR_03.jpg

Investor Relations

  • Investor Overview
  • Corporate Governance
    • Leadership Team
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financials & Filings
    • SEC Filings
    • Quarterly Results
    • Key Ratios
  • Stock Information
    • Historic Stock Lookup
    • Investment Calculator
  • Analyst Coverage
  • Investor FAQs
  • Contact Us
  • Email Alerts

4

Symbol:

Open
High | Low
Volume

Data Provided by Refinitiv. Minimum 15 minutes delayed.

contact

Contact Us

HBIO Investor Presentation – November 2022 1.5 MB

SEC Filing Details

Document Details

Form
4
Filing Date
May 26, 2022
Document Date
May 24, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Harvard Bioscience, Inc.
Issuer
HARVARD BIOSCIENCE INC
Filer
LOY BERTRAND

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Shareholder Tools

Printed Materials
Email Alerts
RSS
Print
Share
  • Facebook
  • LinkedIn
  • Twitter
  • RSS
  • © 2023 Harvard Bioscience, Inc.
  • All rights reserved
  • Privacy Policy.
  • Terms & Conditions
  • Site Map